Biovie Inc Stock Analysis

Biovie Stock Analysis Notes

About 14.0% of the company shares are held by company insiders. The book value of Biovie was currently reported as 2.51. The company recorded a loss per share of 5.08. Biovie Inc last dividend was issued on the 22nd of November 2019. The entity had 1:10 split on the 6th of August 2024. BioVie Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada. BioVie operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 13 people. For more info on Biovie Inc please contact Cuong MBA at 775 888 3162 or go to https://bioviepharma.com.

Biovie Inc Investment Alerts

Biovie Inc Upcoming and Recent Events

Biovie Largest EPS Surprises

View All Earnings Estimates

Biovie Environmental, Social, and Governance (ESG) Scores

Biovie Stock Institutional Investors

Note, although Biovie's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Biovie Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 55.08 M.

Biovie Profitablity

Management Efficiency

Biovie Inc has return on total asset (ROA) of (0.6669) % which means that it has lost $0.6669 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.0826) %, meaning that it created substantial loss on money invested by shareholders. Biovie's management efficiency ratios could be used to measure how well Biovie manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -1.38. The current Return On Capital Employed is estimated to decrease to -2.13. As of now, Biovie's Non Current Assets Total are increasing as compared to previous years. The Biovie's current Other Assets is estimated to increase to 5,509, while Non Currrent Assets Other are projected to decrease to 0.00.

Technical Drivers

As of the 4th of December, Biovie shows the Downside Deviation of 11.93, risk adjusted performance of 0.0709, and Mean Deviation of 7.51. Biovie Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Biovie Inc Price Movement Analysis

Biovie Inc Insider Trading Activities

Biovie Outstanding Bonds

Biovie Predictive Daily Indicators

Biovie Corporate Filings

Biovie Forecast Models

Biovie's time-series forecasting models are one of many Biovie's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biovie's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Biovie prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biovie shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Biovie. By using and applying Biovie Stock analysis, traders can create a robust methodology for identifying Biovie entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Biovie analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Biovie analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Biovie Inc stock analysis indicators help investors evaluate how Biovie stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Biovie shares will generate the highest return on investment. By understating and applying Biovie stock analysis, traders can identify Biovie position entry and exit signals to maximize returns.

When running Biovie's price analysis, check to measure Biovie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biovie is operating at the current time. Most of Biovie's value examination focuses on studying past and present price action to predict the probability of Biovie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biovie's price. Additionally, you may evaluate how the addition of Biovie to your portfolios can decrease your overall portfolio volatility.